tiprankstipranks
Arbutus Biopharma Corporation (GB:0SGC)
LSE:0SGC

Arbutus Biopharma (0SGC) Cash flow

0 Followers

Arbutus Biopharma Cash Flow

GB:0SGC's free cash flow for Q4 2023 was $-17.29M. For the 2023 fiscal year, GB:0SGC's free cash flow was decreased by $-51.06M and operating cash flow was $-17.29M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -85.94M$ -85.94M$ -37.62M$ -67.53M$ -51.44M$ -71.01M
Investing Cash Flow
$ 50.77M$ 50.77M$ -72.71M$ -12.68M$ -14.91M$ 28.34M
Financing Cash Flow
$ 30.65M$ 30.65M$ 31.81M$ 137.24M$ 86.75M$ 37.46M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 111.60M$ 26.29M$ 30.75M$ 109.33M$ 52.25M$ 31.80M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
-----$ 0.00
Issuance Of Capital Stock
$ 535.00K$ 535.00K$ 395.00K$ 135.13M$ 86.30M$ 18.60M
Issuance Of Debt
------
Repayment Of Debt
-----$ 0.00
Free Cash Flow
$ -86.92M$ -86.92M$ -35.87M$ -68.34M$ -51.67M$ -71.59M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Arbutus Biopharma Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis